NEMP2
Nuclear envelope integral membrane protein 2
Also known as: NEMP2_HUMAN, TMEM194B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NFY4
- Gene
- NEMP2
- Ensembl
- ENSG00000189362
- Chromosome
- 2
- Canonical length
- 417 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to be located in nuclear inner membrane. Predicted to be active in nuclear envelope. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
417 residues, UniProt reviewed canonical sequence.
>A6NFY4|NEMP2
1 MGPRQGRWWL LLWLPPLATL PVRGEAAAAA LSVRRCKALK EKDLIRTSES DCYCYNQNSQ
61 VEWKYIWSTM QVKITSPGLF RIVYIAERHN CQYPENILSF IKCVIHNFWI PKESNEITII
121 INPYRETVCF SVEPVKKIFN YMIHVNRNIM DFKLFLVFVA GVFLFFYART LSQSPTFYYS
181 SGTVLGVLMT LVFVLLLVKR FIPKYSTFWA LMVGCWFASV YIVCQLMEDL KWLWYENRIY
241 VLGYVLIVGF FSFVVCYKHG PLADDRSRSL LMWMLRLLSL VLVYAGVAVP QFAYAAIILL
301 MSSWSLHYPL RACSYMRWKM EQWFTSKELV VKYLTEDEYR EQADAETNSA LEELRRACRK
361 PDFPSWLVVS RLHTPSKFAD FVLGGSHLSP EEISLHEEQY GLGGAFLEEQ LFNPSTALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NEMP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 5
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 4.3 nTPM
Expression across tissuesHPA
Tissue
- thymus: 4.3 nTPM
- lymph node: 3.4 nTPM
- testis: 2.8 nTPM
- tonsil: 2.8 nTPM
- appendix: 2.3 nTPM
- cerebellum: 2.3 nTPM
Single-cell type
- epicardial cells: 41 nCPM
- thymocytes: 29 nCPM
- late primary spermatocytes: 23 nCPM
- cardiomyocytes: 22 nCPM
- monocyte progenitors: 17 nCPM
- nk-cells: 17 nCPM
Immune cell
- T-reg: 3.1 nTPM
- naive CD4 T-cell: 2.7 nTPM
- naive CD8 T-cell: 2.3 nTPM
- MAIT T-cell: 2 nTPM
- naive B-cell: 1.9 nTPM
- plasmacytoid DC: 1.9 nTPM
Brain region
- cerebellum: 8.8 nTPM
- white matter: 6 nTPM
- basal ganglia: 5.2 nTPM
- cerebral cortex: 5.2 nTPM
- pons: 5.2 nTPM
- thalamus: 5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NEMP2 as an antibody target. Whether an autoantibody or antibody against NEMP2 could matter depends on whether native NEMP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NEMP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NEMP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...